GFACX | MLRMX | GFACX / MLRMX | |
Total Expense Ratio | 1.36 | 1.19 | 114% |
Annual Report Gross Expense Ratio | 1.36 | 1.20 | 113% |
Fund Existence | 24 years | 5 years | - |
Gain YTD | -2.682 | -3.030 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 284B | 12.7B | 2,236% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 1.60 | -8.96 | -18% |
Returns for 3 years | 28.28 | 10.20 | 277% |
Returns for 5 years | 34.66 | N/A | - |
Returns for 10 years | 45.25 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
KOLD | 21.89 | 0.10 | +0.46% |
ProShares UltraShort Bloomberg Natrl Gas | |||
ETG | 19.27 | 0.05 | +0.26% |
Eaton Vance Tax-Advantaged Global Dividend Income Fund | |||
UAPR | 30.01 | 0.07 | +0.22% |
Innovator U.S. Equity Ultra BffrETF™-Apr | |||
DWAT | 11.71 | 0.01 | +0.07% |
Arrow DWA Tactical Macro ETF | |||
BIB | 41.24 | -0.32 | -0.77% |
ProShares Ultra Nasdaq Biotechnology |